Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Hydroxychloroquine shown to slow recovery for COVID-19 patients

Hydroxychloroquine shown to slow recovery for COVID-19 patients

A new approach to prevent autoimmune diseases associated with aging

A new approach to prevent autoimmune diseases associated with aging

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Online searches for unproven therapies for COVID-19

Online searches for unproven therapies for COVID-19

Testing of hydroxychloroquine for COVID-19 begins at Montefiore And Einstein

Testing of hydroxychloroquine for COVID-19 begins at Montefiore And Einstein

Arthritis drug assessed as potential treatment for COVID-19-related pneumonia

Arthritis drug assessed as potential treatment for COVID-19-related pneumonia

The challenges of keeping young adults safe during the pandemic

The challenges of keeping young adults safe during the pandemic

C-Path receives EMA’s letter of support to facilitate the diagnoses of type 1 diabetes

C-Path receives EMA’s letter of support to facilitate the diagnoses of type 1 diabetes

New light-activated drug delivery method helps confine arthritis treatments to the joints

New light-activated drug delivery method helps confine arthritis treatments to the joints

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

A new method to deliver therapeutic proteins inside the body

A new method to deliver therapeutic proteins inside the body

Is hydroxychloroquine effective against COVID-19?

Is hydroxychloroquine effective against COVID-19?

Many phase II trials overestimate drug efficacy, pose a barrier in drug licensing

Many phase II trials overestimate drug efficacy, pose a barrier in drug licensing

Are overactive immune cells causing COVID-19-related deaths?

Are overactive immune cells causing COVID-19-related deaths?

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

'Chaperone protein' protects against autoimmune diseases, mice study shows

'Chaperone protein' protects against autoimmune diseases, mice study shows

Discovery of T cells response spectrum could new shed light on immune diseases

Discovery of T cells response spectrum could new shed light on immune diseases

In shutting out threat, seniors in continuing care communities feel shut in

In shutting out threat, seniors in continuing care communities feel shut in

New insights into the building blocks of periodontitis

New insights into the building blocks of periodontitis